ArticleScientific reports2025
Epidemiological characteristics of imported malaria related to international travel in the Republic of Korea from 2009 to 2018.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Epidemiological and entomological analysis of imported malaria in Pemba Island, Zanzibar: a study from 2020-2022.Malaria journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria, transmitted by mosquitoes infected with Plasmodium parasites, remains a significant health issue with global travel increasing the risk of imported malaria. This study investigates imported malaria cases in the Republic of Korea from 2009 to 2018 using data from the Korea National Infectious Disease Surveillance System. During this period, 601 imported cases were reported, with 82.4% male patients and a median age of 39.1 years. Most cases (76.5%) involved Korean residents returning from malaria-endemic areas, mainly Africa and Asia. Plasmodium falciparum (55.7%) and Plasmodium vivax (30.3%) were the predominant species. The annual percent change in incidence rate was 6.45%. Notably, 71.5% of the patients did not receive prophylactic chemotherapy, and 18% of those who did still developed malaria. Median diagnostic delays were 4 days for P. falciparum and 7 days for P. vivax. The case fatality rate was 2.3%, with all deaths occurring in travelers who contracted P. falciparum in Africa. This study emphasizes the ongoing risk of imported malaria in the ROK and highlights the need for better awareness and preventive measures among travelers. Enhancing surveillance and educating travelers on anti-malaria chemoprophylaxis are crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.